Skip to main content
Clinical Trials/NCT04205760
NCT04205760UnknownPhase 3

Preoperative Nutritional Optimization and Physical Exercise for Patients Scheduled for Elective Implantation for a Left-Ventricular Assist Device

RWTH Aachen University5 sites in 1 country40 target enrollmentStarted: January 2, 2022Last updated:
Conditions

Trial Snapshot

Phase
Phase 3
Enrollment
40
Locations
5
Primary Endpoint
Separation of caloric supplementation

Study Overview

Brief Summary

This is a pilot, randomized, multicenter interventional trial of a combined preoperative oral nutritional support (ONS) and physical exercise therapy in patients planned for elective implantation of a left-ventricular assist device (LVAD). This pilot study pursues to demonstrate the feasibility and safety of a study protocol to optimize the patients' nutritional and physical state to reduce the number of postoperative complications and consequently to ameliorate the patients' outcome.

Detailed Description

The oral nutrition supplementation will be started immediately after randomization and will be continued until surgery. The patients will receive a dosage of ONS adjusted to their nutritional risk. Regular monitoring of blood sugars, electrolytes, phosphate, and triglycerides will occur twice per week, as per standard protocol.

In-bed cycling will be started as soon as possible after randomization. Cycling sessions will be performed daily for 50 minutes, at least 5 times a week until surgery. Standard safety criteria will be assessed prior to initiating cycling treatments. The in-bed cycling will be performed passively or actively with graded increasing resistance. All cycling interventions will be performed under 1:1 supervision of medically trained study personnel while monitoring patient's heart rate, systolic and diastolic blood pressure and transcutaneous oxygen saturation of blood.

When evaluating the effect of a combined nutritional and exercise intervention, other important co-interventions should be standardized to reduce potential confounding of trial outcomes. All study patients should be fed with an oral diet that is in accordance to local standards, whereas it is strongly recommended to adhere to current clinical practice guidelines. Besides, the investigators highly encourage daily respiratory therapy in both groups plus mobilization as much as feasible.

All other key interventions during preoperative treatment will be standardized in accordance to the local clinical practice. Study teams will follow up on the patients on a daily base, documenting adherence with study interventions and key co-interventions.

Patients in the control group will not receive preoperative ONS. No bed cycling will be allowed from admission until surgery. Neither of these practices are the current standard of care in the participating unit.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Masking Description

functional outcome assessor will be blinded to study group allocation

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Given informed consent
  • Adult patients (≥18 years)
  • Patients undergoing elective LVAD implantation Additional cardiac surgery, such as bypass grafting, or valve repair is permitted

Exclusion Criteria

  • Hospital admission <5 days prior to planned LVAD implantation
  • Patients on ECMO or INTERMACS<1
  • Patients already receiving nutrition support on hospital admission
  • Enteral nutrition is contraindicated.
  • Pregnant or lactating patients
  • Patients with clinical fulminant hepatic failure
  • Patients with cirrhosis Child's Class C Liver Disease
  • Patients with clinical kidney failure or requiring hemodialysis
  • Known allergy or intolerance to study nutrients
  • Intracranial or spinal process affecting motor function
  • Lower extremity impairments that prevent cycling
  • Disabling neuropsychiatric disorders or language barriers
  • Weight > 150 kg
  • Enrolment in an industry sponsored randomized trial within the last 30 days (co-enrolment in academic randomized trials will be considered on a case by case basis)

Outcomes

Primary Outcomes

Separation of caloric supplementation

Time Frame: up to 2 weeks before surgery

Separation between groups on prescribed caloric targets

Comparison of adverse events

Time Frame: up to 2 weeks before surgery

adverse events between groups related to cycling and nutritional complications

Separation of protein supplementation

Time Frame: up to 2 weeks before surgery

Separation between groups on prescribed protein targets

Proportion of interventions received as prescribed

Time Frame: up to 2 weeks before surgery

Proportion of interventions received as prescribed

Rate of patients recruited per month

Time Frame: up to 18 months

Target: 1.5 patients per month

Ratio of control patients received physiotherapy

Time Frame: up to 2 weeks before surgery

Ratio of control patients received physiotherapy

Ratio of control patients received nutritional support

Time Frame: up to 2 weeks before surgery

Ratio of control patients received nutritional support

Secondary Outcomes

  • mortality rates at day 30(day 30 after randomization)
  • Mean duration of mechanical ventilation(up to 3 months)
  • Quality of life - Short Form 36 (SF-36)(up to 6 months)
  • rates of ICU length of stay(up to 3 months)
  • Incidence of complications(up to 3 months)
  • Incidence of infections(up to 3 months)
  • Change in Muscle strength - Handgrip strength(up to 6 months)
  • Change in Physical function - Functional Status Score for the ICU(up to 6 months)
  • rates of hospital length of stay(up to 3 months)
  • Change in Mid-arm circumference(up to 6 months)
  • Change in Muscle mass - Quadriceps thickness(up to 6 months)
  • Change in Physical function - Short Physical Performance Battery(up to 6 months)
  • Change in Muscle mass - Quadriceps cross sectional area(up to 6 months)
  • Change in Muscle strength - Quadriceps strength(up to 6 months)
  • Change of Clinical Frailty score (CFS)(up to 6 months)
  • Change in Physical function - 6-Minute Walk Test(up to 6 months)
  • Change in quality of life - Lawton Instrumental Activities of Daily Living (IADL)(up to 6 months)
  • Change in quality of life - Katz Activities of Daily Living (ADL)(up to 6 months)
  • Change in neurological function - Mini Mental State Examination(up to 6 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Christian Stoppe

Prof. Dr. med.

RWTH Aachen University

Study Sites (5)

Loading locations...

Similar Trials

Preoperative Nutritional Optimization and... | Clinical Trial